These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12775762)

  • 1. Protection and compensation in the influenza virus-specific CD8+ T cell response.
    Webby RJ; Andreansky S; Stambas J; Rehg JE; Webster RG; Doherty PC; Turner SJ
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7235-40. PubMed ID: 12775762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.
    Belz GT; Xie W; Altman JD; Doherty PC
    J Virol; 2000 Apr; 74(8):3486-93. PubMed ID: 10729122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses.
    Thomas PG; Brown SA; Keating R; Yue W; Morris MY; So J; Webby RJ; Doherty PC
    J Immunol; 2007 Mar; 178(5):3091-8. PubMed ID: 17312156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses.
    Andreansky SS; Stambas J; Thomas PG; Xie W; Webby RJ; Doherty PC
    J Virol; 2005 Apr; 79(7):4329-39. PubMed ID: 15767433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.
    Turner SJ; La Gruta NL; Stambas J; Diaz G; Doherty PC
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3545-50. PubMed ID: 14993609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting.
    Jenkins MR; Webby R; Doherty PC; Turner SJ
    J Immunol; 2006 Sep; 177(5):2917-25. PubMed ID: 16920927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand preferentially modulates immune response and enhances protection against influenza virus.
    Hashem AM; Gravel C; Chen Z; Yi Y; Tocchi M; Jaentschke B; Fan X; Li C; Rosu-Myles M; Pereboev A; He R; Wang J; Li X
    J Immunol; 2014 Jul; 193(2):722-34. PubMed ID: 24928989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.
    Zhong W; Liu F; Dong L; Lu X; Hancock K; Reinherz EL; Katz JM; Sambhara S
    PLoS One; 2010 May; 5(5):e10583. PubMed ID: 20485501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig.
    Topham DJ; Tripp RA; Hamilton-Easton AM; Sarawar SR; Doherty PC
    J Immunol; 1996 Oct; 157(7):2947-52. PubMed ID: 8816401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.
    Machkovech HM; Bedford T; Suchard MA; Bloom JD
    J Virol; 2015 Nov; 89(22):11275-83. PubMed ID: 26311880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
    La Gruta NL; Turner SJ; Doherty PC
    J Immunol; 2004 May; 172(9):5553-60. PubMed ID: 15100298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of suboptimal priming are apparent for low-avidity T-cell responses.
    Venturi V; Davenport MP; Swan NG; Doherty PC; Kedzierska K
    Immunol Cell Biol; 2012 Feb; 90(2):216-23. PubMed ID: 21556018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixing an irrelevant TCR alpha chain reveals the importance of TCR beta diversity for optimal TCR alpha beta pairing and function of virus-specific CD8+ T cells.
    Valkenburg SA; Day EB; Swan NG; Croom HA; Carbone FR; Doherty PC; Turner SJ; Kedzierska K
    Eur J Immunol; 2010 Sep; 40(9):2470-81. PubMed ID: 20690181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of preexisting immunity to influenza on responses to influenza vectors in mice.
    Langley WA; Bradley KC; Li ZN; Talekar GR; Galloway SE; Steinhauer DA
    Vaccine; 2010 Aug; 28(38):6305-13. PubMed ID: 20656032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection.
    Stitz L; Schmitz C; Binder D; Zinkernagel R; Paoletti E; Becht H
    J Gen Virol; 1990 May; 71 ( Pt 5)():1169-79. PubMed ID: 1693165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.
    Baranowska M; Hauge AG; Hoornaert C; Bogen B; Grødeland G
    Vaccine; 2015 Dec; 33(49):6988-96. PubMed ID: 26387432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent naive and memory CD8(+) T cell responses to an influenza A virus.
    Turner SJ; Cross R; Xie W; Doherty PC
    J Immunol; 2001 Sep; 167(5):2753-8. PubMed ID: 11509619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.